首页> 外文期刊>Transfusion and apheresis science: official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis >Kell hemolytic disease of the fetus. Combination treatment with plasmapheresis and intrauterine blood transfusion.
【24h】

Kell hemolytic disease of the fetus. Combination treatment with plasmapheresis and intrauterine blood transfusion.

机译:胎儿的凯尔溶血病。血浆置换术和宫内输血联合治疗。

获取原文
获取原文并翻译 | 示例
           

摘要

We report the case of a 36-year old pregnant woman with a Kell alloimmunization (anti-K1), probably secondary to a previous blood transfusion, and a severe hemolytic disease of the fetus. Once the first fetal blood transfusion by cordocentesis was performed, we started treatment with repeated plasmapheresis to maintain anti-K1 titer below 1:32. With this scheme we did not need to perform a second intrauterine fetal blood transfusion and only mild anemia was found in the newborn. Taking into account that the rate of serious complications with plasmapheresis is lower than that related with intrauterine blood transfusion, this could be an alternative approach to repeated transfusions.
机译:我们报道了一名36岁孕妇的凯氏同种免疫(抗K1)病例,该病例可能继发于先前的输血,并伴有严重的胎儿溶血性疾病。一旦通过脐穿术进行了第一次胎儿输血,我们就开始进行重复血浆置换治疗,以将抗K1滴度保持在1:32以下。通过这种方案,我们无需进行第二次宫内胎儿输血,而新生儿中仅发现轻度贫血。考虑到血浆置换的严重并发症发生率低于与子宫内输血相关的并发症发生率,这可能是重复输血的另一种方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号